Laura Luddington

Laura has over 10 years’ experience in the drug development process including Phase I, (FIH) pharmacology/PK studies and Phase III and IV studies.

She previously worked within the Welsh Ambulance Service where she supported the growth of pre-hospital research in Wales and facilitated the conduct of numerous trials including cardiac arrest, stroke, transient ischaemic attacks, and hip fractures.

Laura has over 3 years of NHS research experience that has also included a role of Clinical Trials Coordinator for the Aneurin Bevan University Health Board that included facilitation and coordination of commercial and non-commercial trials across several specialities including oncology, respiratory, surgical and emergency care.

Since joining Simbec-Orion in 2017, Laura has managed and successfully executed a range of study designs including complex and adaptive Phase 1, First In Human/pharmacology, drug-drug interactions, bioequivalence and scintigraphy, as single and multicentred studies, across numerous clinical indications in both healthy and patient populations.